Virbac's first half 2021 figures are now out.
"companion animal activities grew by +24.3% overall ... essentially driven by the remarkable double digit growth of the specialty ranges (including Clomicalm, Movoflec, Stelfonta)..."
interesting.
- Forums
- ASX - By Stock
- Qbiotics
Virbac's first half 2021 figures are now out."companion...
-
- There are more pages in this discussion • 875 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online